secwatch.observer — SEC 8-K summary
======================================

Issuer:     RxSight, Inc. (RXST)
CIK:        0001111485
Form:       8-K
Filed at:   2021-11-10T23:59:59+00:00
Accession:  0000950170-21-004078
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RxSight Q3 2021 revenue $5.8M (+39% YoY); net loss $12.7M; FY revenue guidance $21.0-$21.4M
--------------------------------------------------------------------------------

- Q3 revenue $5.8M, up 39% YoY and 18% QoQ; 31 LDDs sold, installed base 161.
- Net loss $(12.7)M ($(0.68)/share) vs net income $5.9M in Q3 2020; adjusted net loss $(12.2)M ($(0.65)/share).
- Cash and investments $168.3M; long-term debt $39.6M as of Sep 30, 2021.
- FY 2021 revenue guidance $21.0M-$21.4M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1111485/000095017021004078/0000950170-21-004078-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1111485/000095017021004078/rxst-20211110.htm
  HTML page:      https://secwatch.observer/filing/0000950170-21-004078

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer